Owner GLAXO GROUP LIMITED

Inventors BORTHWICK, Alan, David; CAMPBELL, Matthew; CHAN, Chuen; KELLY, Henry, Anderson; KING, Nigel, Paul; KLEANTHOUS, Savvas; MASON, Andrew, McMurtrie; SENGER, Stefan; SMITH, Paul, William; WATSON, Nigel, Stephen; YOUNG, Robert, John

Pub. Number AU-A-2002339158

PCT Number PCT/GB02/05134

PCT Pub. Number WO2003/043981

Priority 0127568.4 16.11.01 GB

Filing date 13 November 2002

Wipo publication date 10 June 2003

C07D 207/26 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 031/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 031/4015 - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

A61P 009/10 Drugs for disorders of the cardiovascular system

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom